Defiance Daily is trading at 98.67 as of the 30th of November 2024; that is 1.76 percent decrease since the beginning of the trading day. The etf's open price was 100.44. Defiance Daily has about a 25 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat solid performance during the last 90 days. Equity ratings for Defiance Daily Target are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Mast Therapeutics, Inc., a clinicalstage biopharmaceutical company, develops therapies for serious or lifethreatening diseases with significant unmet needs. The company has 254.75 M outstanding shares of which 7.1 M shares are now shorted by private and institutional investors with about 0.0 trading days to cover. More on Defiance Daily Target
Defiance Daily Target [MSTX] is traded in USA and was established null. The fund is listed under Trading--Leveraged Equity category and is part of null family. The entity is thematically classified as Single Stock ETFs. Defiance Daily Target now have in assets.
Defiance Daily Target currently holds about 23.05 M in cash with (32.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11.
Check Defiance Daily Probability Of Bankruptcy
Defiance Daily Target Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Defiance Daily. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
When determining whether Defiance Daily Target is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Defiance Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Defiance Daily Target Etf. Highlighted below are key reports to facilitate an investment decision about Defiance Daily Target Etf:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Defiance Daily Target. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
The market value of Defiance Daily Target is measured differently than its book value, which is the value of Defiance that is recorded on the company's balance sheet. Investors also form their own opinion of Defiance Daily's value that differs from its market value or its book value, called intrinsic value, which is Defiance Daily's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Defiance Daily's market value can be influenced by many factors that don't directly affect Defiance Daily's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Defiance Daily's value and its price as these two are different measures arrived at by different means. Investors typically determine if Defiance Daily is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Defiance Daily's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.